Eli Lilly

Eli Lilly is a top pharmaceutical company based in Indianapolis, Indiana, USA

Eli Lilly is a top pharmaceutical company based in Indianapolis, Indiana, USA.The company was founded in 1876.

Eli Lilly is engaged in the discovery, development, manufacture and sale of pharmaceutical and animal health products worldwide.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Eli Lilly

Eli Lilly is a top pharmaceutical company based in Indianapolis, Indiana, USA.

The company was founded in 1876.

Eli Lilly is engaged in the discovery, development, manufacture and sale of pharmaceutical and animal health products worldwide.

The company has two core businesses; all focused on advancing innovations that provide better options and outcomes, enabling healthier lives.

  • Pharmaceuticals – the company offers branded medicines, with a focus on cardiovascular, diabetes, critical care, oncology, neuroscience, men’s health and musculoskeletal.
  • Animal health – the company complements its pharma business through its animal health subsidiary, Elanco, with a focus on animal protein production, companion animal health and food safety.

Eli Lilly has an active licensing partnering group that recognizes the significant role played by 3rd party collaborations in delivering great opportunities. Eli Lilly has a long history of partnering, building numerous collaborative partnerships more

Eli Lilly announced over 150 partnering / licensing deals since 2005, with over 14 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in metabolic, oncology, psychiatry, central nervous system and cardiovascular diseases more

Eli Lilly has also announced over 9 M&A deals since 2005, with the lead deals being the acquisition of Imclone Systems and Icos more

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Eli Lilly

Examples of recent partnering and licensing deals announced by Eli Lilly can be viewed in Current Partnering's Eli Lilly partnering activity review article.

Examples of recent M&A deals announced by Eli Lilly can be viewed in Current Partnering's Eli Lilly M&A activity review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Eli Lilly

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Eli Lilly

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for Eli Lilly

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Eli Lilly company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals
Review
– monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email
cabannerad300x150new4gif
rauconbadgejpg
e80banner300x150animgif
cabannerad300x150new4gif
e80banner300x150animgif
a1banner300x150animgif